Simplex Trading’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.8K Buy
9,700
+9,300
+2,325% +$73.3K ﹤0.01% 5769
2026
Q1
$2.72K Hold
400
﹤0.01% 8235
2025
Q4
$3.37K Buy
+400
New +$4.42K ﹤0.01% 7630
2025
Q2
Sell
-150
Closed -$1K 8487
2025
Q1
$1K Buy
+150
New +$2.15K ﹤0.01% 8127
2024
Q2
Sell
-181
Closed -$6K 8641
2024
Q1
$6K Sell
181
-1,163
-87% -$48.1K ﹤0.01% 7882
2023
Q4
$40K Hold
1,344
﹤0.01% 6286
2023
Q3
$29K Buy
1,344
+719
+115% +$25.4K ﹤0.01% 6275
2023
Q2
$24K Buy
625
+312
+100% +$27.5K ﹤0.01% 6565
2023
Q1
$28K Sell
313
-50
-14% -$6.28K ﹤0.01% 6542
2022
Q4
$51K Sell
363
-1,793
-83% -$447K ﹤0.01% 5857
2022
Q3
$490K Buy
+2,156
New +$547K ﹤0.01% 3493
2022
Q2
Sell
-150
Closed -$47K 9812
2022
Q1
$47K Sell
150
-2,850
-95% -$656K ﹤0.01% 7207
2021
Q4
$839K Buy
3,000
+2,987
+22,977% +$513K ﹤0.01% 3096
2021
Q3
$1K Hold
13
﹤0.01% 9611
2021
Q2
$2K Buy
+13
New +$2.65K ﹤0.01% 9682
2020
Q2
Sell
-3
Closed -$32K 7495
2020
Q1
$32K Buy
+3
New +$445 ﹤0.01% 5552
2019
Q4
Hold
0
6847

Other funds holding ACET

Simplex Trading's ACET Position: Q2 2026 in Review

Simplex Trading increased its Adicet Bio (ACET) stake by 246% in Q2 2026, buying an estimated $27K and bringing the position to 4,814 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6471.

Simplex Trading first reported a position in ACET in Q4 2019 and has held it in 18 quarters since. The position peaked at $295K in Q4 2021. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Simplex Trading held 4,814 shares of Adicet Bio worth $41.6K as of Q2 2026.
  • Simplex Trading bought 3,421 Adicet Bio shares in Q2 2026, an estimated $27K.
  • Adicet Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6471 holding.
  • Simplex Trading first reported a position in Adicet Bio in Q4 2019 and has held it in 18 quarters since.
  • Simplex Trading's Adicet Bio position peaked at $295K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.